
Over the last 7 days, the Life Sciences industry has dropped 1.9%, driven by Shin Nippon Biomedical Laboratories declining 4.3%. On the other hand Immuno-Biological Laboratories is actually up 11%. However, the industry is down 6.8% over the past year. As for the next few years, earnings are expected to grow by 17% per annum.
Has the Japanese Life Sciences Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 03 Jan 2026 | JP¥151.2b | JP¥66.9b | JP¥72.2m | 21.7x | 2094.5x | 2.3x |
| Mon, 01 Dec 2025 | JP¥171.9b | JP¥67.3b | JP¥574.9m | 18.1x | 298.9x | 2.6x |
| Wed, 29 Oct 2025 | JP¥134.0b | JP¥66.5b | JP¥1.5b | 15.9x | 91.8x | 2x |
| Fri, 26 Sep 2025 | JP¥148.8b | JP¥66.5b | JP¥1.5b | 16.8x | 102x | 2.2x |
| Sun, 24 Aug 2025 | JP¥149.7b | JP¥66.5b | JP¥1.5b | 17.2x | 102.6x | 2.3x |
| Tue, 22 Jul 2025 | JP¥137.7b | JP¥66.0b | JP¥1.1b | 16.2x | 122x | 2.1x |
| Thu, 19 Jun 2025 | JP¥142.8b | JP¥66.0b | JP¥1.1b | 16.8x | 126.1x | 2.2x |
| Sat, 17 May 2025 | JP¥135.1b | JP¥65.9b | JP¥1.4b | 15x | 95.2x | 2x |
| Mon, 14 Apr 2025 | JP¥129.7b | JP¥63.8b | JP¥963.0m | 13.5x | 134.7x | 2x |
| Wed, 12 Mar 2025 | JP¥156.8b | JP¥65.1b | JP¥1.1b | 15.4x | 140.6x | 2.4x |
| Fri, 07 Feb 2025 | JP¥175.2b | JP¥65.6b | JP¥1.5b | 15.8x | 117.9x | 2.7x |
| Sun, 05 Jan 2025 | JP¥165.9b | JP¥62.0b | JP¥440.7m | 17.8x | 376.4x | 2.7x |
| Tue, 03 Dec 2024 | JP¥166.4b | JP¥62.0b | JP¥825.9m | 17.3x | 201.4x | 2.7x |
| Thu, 31 Oct 2024 | JP¥150.8b | JP¥61.5b | JP¥1.8b | 21.4x | 81.9x | 2.5x |
| Sat, 28 Sep 2024 | JP¥157.2b | JP¥61.5b | JP¥1.8b | 18.5x | 85.4x | 2.6x |
| Mon, 26 Aug 2024 | JP¥166.8b | JP¥61.5b | JP¥2.1b | 19.3x | 79.1x | 2.7x |
| Wed, 24 Jul 2024 | JP¥166.4b | JP¥61.8b | JP¥3.2b | 25.8x | 51.4x | 2.7x |
| Fri, 21 Jun 2024 | JP¥164.7b | JP¥61.8b | JP¥3.2b | 25.8x | 50.9x | 2.7x |
| Sun, 19 May 2024 | JP¥168.2b | JP¥62.0b | JP¥3.1b | 13.7x | 53.9x | 2.7x |
| Tue, 16 Apr 2024 | JP¥184.0b | JP¥62.3b | JP¥3.3b | 14.5x | 55.9x | 3x |
| Thu, 14 Mar 2024 | JP¥229.5b | JP¥155.4b | JP¥8.6b | 13.9x | 26.6x | 1.5x |
| Sat, 10 Feb 2024 | JP¥232.8b | JP¥155.4b | JP¥8.4b | 14.7x | 27.9x | 1.5x |
| Mon, 08 Jan 2024 | JP¥230.3b | JP¥167.1b | JP¥8.5b | 15.5x | 27.1x | 1.4x |
| Wed, 06 Dec 2023 | JP¥236.0b | JP¥167.4b | JP¥8.7b | 15x | 27.2x | 1.4x |
| Fri, 03 Nov 2023 | JP¥225.7b | JP¥179.3b | JP¥12.8b | 14.3x | 17.7x | 1.3x |
| Sun, 01 Oct 2023 | JP¥252.2b | JP¥179.3b | JP¥12.8b | 15.6x | 19.7x | 1.4x |
| Tue, 29 Aug 2023 | JP¥264.4b | JP¥179.3b | JP¥12.8b | 16.5x | 20.7x | 1.5x |
| Thu, 27 Jul 2023 | JP¥270.4b | JP¥178.7b | JP¥15.7b | 16.3x | 17.3x | 1.5x |
| Sat, 24 Jun 2023 | JP¥285.8b | JP¥178.5b | JP¥16.2b | 17.1x | 17.6x | 1.6x |
| Mon, 22 May 2023 | JP¥280.2b | JP¥178.1b | JP¥15.9b | 15.6x | 17.6x | 1.6x |
| Wed, 19 Apr 2023 | JP¥296.0b | JP¥171.9b | JP¥13.3b | 16.8x | 22.3x | 1.7x |
| Fri, 17 Mar 2023 | JP¥309.2b | JP¥171.9b | JP¥13.3b | 16.4x | 23.3x | 1.8x |
| Sun, 12 Feb 2023 | JP¥301.4b | JP¥172.2b | JP¥14.3b | 16.6x | 21.1x | 1.7x |
| Tue, 10 Jan 2023 | JP¥288.3b | JP¥166.1b | JP¥16.2b | 14.6x | 17.8x | 1.7x |
17.8x
Which industries have driven the changes within the Japanese Healthcare industry?
| JP Market | -0.23% | |
| Healthcare | -0.70% | |
| Life Sciences | -1.92% | |
| Clinical Research and Equipment | -1.92% | |
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 4570 Immuno-Biological Laboratories | JP¥1.90k | 11.3% +JP¥1.8b | 311.1% | PE55.3x | |
| 2370 MEDINET | JP¥29.00 | 3.6% +JP¥264.7m | -19.4% | n/a | |
| 4892 Cyfuse Biomedical K.K | JP¥590.00 | 2.6% +JP¥124.6m | 30.5% | PS55.1x | |
| 7707 Precision System Science | JP¥186.00 | 2.2% +JP¥108.8m | -19.1% | PS1x | |
| 6090 Human Metabolome Technologies | JP¥660.00 | 2.5% +JP¥90.6m | 7.5% | PE19.3x |